Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,006 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing.
Asano G, Miyabe K, Kato H, Yoshida M, Sawada T, Okamoto Y, Sahashi H, Atsuta N, Kachi K, Kato A, Jinno N, Natsume M, Hori Y, Naitoh I, Hayashi K, Matsuo Y, Takahashi S, Suzuki H, Kataoka H. Asano G, et al. Among authors: kato a, kato h. Sci Rep. 2022 Jan 10;12(1):419. doi: 10.1038/s41598-021-04335-z. Sci Rep. 2022. PMID: 35013462 Free PMC article.
PBK expression predicts favorable survival in colorectal cancer patients.
Nagano-Matsuo A, Inoue S, Koshino A, Ota A, Nakao K, Komura M, Kato H, Naiki-Ito A, Watanabe K, Nagayasu Y, Hosokawa Y, Takiguchi S, Kasugai K, Kasai K, Inaguma S, Takahashi S. Nagano-Matsuo A, et al. Among authors: kato h. Virchows Arch. 2021 Aug;479(2):277-284. doi: 10.1007/s00428-021-03062-0. Epub 2021 Feb 27. Virchows Arch. 2021. PMID: 33638656
Low RAI2 expression is a marker of poor prognosis in breast cancer.
Nishikawa S, Uemoto Y, Kim TS, Hisada T, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Katagiri Y, Terada M, Kato A, Dong Y, Sugiura H, Okuda K, Kato H, Osaga S, Takahashi S, Toyama T. Nishikawa S, et al. Among authors: kato a, kato h. Breast Cancer Res Treat. 2021 May;187(1):81-93. doi: 10.1007/s10549-021-06176-w. Epub 2021 Mar 29. Breast Cancer Res Treat. 2021. PMID: 33782811
Low HECTD1 mRNA expression is associated with poor prognosis and may be correlated with increased mitochondrial respiratory function in breast cancer.
Uemoto Y, Katsuta E, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Terada M, Kato A, Okuda K, Sugiura H, Komura M, Kato H, Osaga S, Takahashi S, Toyama T. Uemoto Y, et al. Among authors: kato a, kato h. Am J Cancer Res. 2022 Apr 15;12(4):1593-1605. eCollection 2022. Am J Cancer Res. 2022. PMID: 35530276 Free PMC article.
Class III β-Tubulin Expression Is of Value in Selecting nab -Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer.
Kato A, Naitoh I, Naiki-Ito A, Hayashi K, Okumura F, Fujita Y, Sano H, Nishi Y, Miyabe K, Inoue T, Hirano A, Takada H, Yoshida M, Hori Y, Natsume M, Kato H, Takahashi S, Kataoka H. Kato A, et al. Among authors: kato h. Pancreas. 2022 Apr 1;51(4):372-379. doi: 10.1097/MPA.0000000000002032. Epub 2022 Jun 12. Pancreas. 2022. PMID: 35695793
Concomitant Pancreatic Ductal Adenocarcinoma and Type 1 Autoimmune Pancreatitis: A Potential Issue in the Diagnosis of Carcinoma by Endoscopic Ultrasound-guided Fine-needle Biopsy.
Kachi K, Naitoh I, Ban T, Hayashi K, Yoshida M, Hori Y, Natsume M, Kato A, Kito Y, Saito K, Matsuo Y, Kato H, Naiki-Ito A, Takahashi S, Notohara K, Kataoka H. Kachi K, et al. Among authors: kato a, kato h. Intern Med. 2023 Feb 15;62(4):545-551. doi: 10.2169/internalmedicine.0075-22. Epub 2022 Jul 14. Intern Med. 2023. PMID: 35831103 Free PMC article.
Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer.
Hisada T, Kondo N, Wanifuchi-Endo Y, Osaga S, Fujita T, Asano T, Uemoto Y, Nishikawa S, Katagiri Y, Terada M, Kato A, Sugiura H, Okuda K, Kato H, Komura M, Morita S, Takahashi S, Toyama T. Hisada T, et al. Among authors: kato a, kato h. Sci Rep. 2022 Oct 3;12(1):16515. doi: 10.1038/s41598-022-20225-4. Sci Rep. 2022. PMID: 36192404 Free PMC article.
Low TINAGL1 expression is a marker for poor prognosis in breast cancer.
Kato A, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Uemoto Y, Terada M, Kato H, Komura M, Okuda K, Takahashi S, Toyama T. Kato A, et al. Among authors: kato h. J Cancer Res Clin Oncol. 2023 Jul;149(8):4771-4782. doi: 10.1007/s00432-022-04394-3. Epub 2022 Oct 14. J Cancer Res Clin Oncol. 2023. PMID: 36229542
9,006 results